FUKUDA DENSHI USA Inc

What FUKUDA DENSHI USA Inc does

Fukuda Denshi USA, Inc. is the US sales and support subsidiary of Fukuda Denshi Co., Ltd., a Tokyo Stock Exchange-listed Japanese medical device company (TSE: 6960) founded in 1949. The US entity, established in 1996 and headquartered in Redmond, Washington, sells cardiology instrumentation and patient monitoring solutions to hospitals, cardiology departments, intensive care units, and vascular medicine specialists. Its product portfolio spans four categories: Cardiology (CardiMax resting and stress ECG systems), Patient Monitoring (DYNASCOPE central monitors, bedside monitors, and telemetry transmitters), Vascular Screening (VaSera VS-2000 for arterial stiffness and cardiovascular risk), and Data Management Software (VSS-50, CVW-6000, EFS-1000). The underlying technology integrates proprietary arrhythmia detection algorithms — covering 28 arrhythmia types plus automatic Early Warning Score calculation — with hardware form factors ranging from compact 1.2kg portable ECG units to IPX8-rated telemetry transmitters and 32-bed central stations.

The business operates on a direct enterprise sales model, with quote-based pricing for capital medical equipment sold through wholly-owned regional offices in the USA, UK, China, Singapore, and Japan. Revenue streams include one-time hardware sales of ECG machines, patient monitors, telemetry systems, and vascular screening devices; software licenses for data management and central viewing workstations; and recurring revenue from compatible accessories, SpO2 sensors, and replacement parts for the installed base. Distribution is exclusively B2B and direct — no consumer channels or third-party resellers for the US market are disclosed. Recent strategic activity has centered on a multi-year product refresh (DS-1800 central monitor, DS-1200/BDS-1001 bedside monitors, CardiMax FX-9800, EFS-1000 data management, LX-1300 telemetry transmitter) and the May 2022 launch of a dedicated US customer website, fukudaamerica.com. Parent-level financials indicate a multi-year revenue contraction, with the topline declining from approximately ¥1,085B in FY2022 to ¥880B in FY2026.

Name

FUKUDA DENSHI USA Inc

Legal name

Fukuda Denshi Co., Ltd.

Website

https://fukuda.com

Company type

Public

Founded year

1949

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Fukuda Denshi USA Inc is the Redmond, WA-based US subsidiary of Tokyo-listed Fukuda Denshi Co., Ltd., selling ECG systems, patient monitors, telemetry transmitters, and vascular screening devices to hospitals, cardiology departments, ICUs, and vascular medicine specialists via direct enterprise sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Redmond

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: Primary revenue from sale of medical monitoring and diagnostic equipment including ECG machines, patient monitors, telemetry systems, vascular screening devices, and related accessories and peripherals.
2. Software and Data Management Systems: Revenue from software products including VSS-50 data management software, CVW-6000 central viewer workstation, and EFS-1000 ECG data management systems.
3. Accessories and Consumables: Ongoing revenue from compatible accessories, SpO2 sensors, and replacement parts for installed base of monitoring equipment.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

No verifiable source content was provided for this extraction. Based on the limited context available, FUKUDA DENSHI USA Inc is described as a medical device company that manufactures and sells ECG machines, patient monitors, telemetry transmitters, and vascular screening systems. The U.S. subsidiary distributes medical monitoring and diagnostic equipment originally developed by its Japanese parent, Fukuda Denshi Co., Ltd.

Product overview

Fukuda Denshi USA Inc offers a comprehensive portfolio of medical monitoring and diagnostic products organized across four main categories: Cardiology (resting ECG and stress test electrocardiographs under the CardiMax brand), Patient Monitoring (central monitors, bedside monitors, and telemetry transmitters under the DYNASCOPE brand), Vascular Screening (VaSera VS-2000 system), and associated data management software (VSS-50, CVW-6000, EFS-1000). The product architecture consists of dedicated hardware devices for data acquisition (ECG machines, monitors, transmitters) complemented by software solutions for data management, viewing, and connectivity. DYNASCOPE central monitors (DS-1800, DS-1700) serve as hub systems that aggregate data from bedside monitors (DS-1200, DS-1001, DS-8100, DS-8400, DS-8007) and telemetry transmitters (LX-1300, LX-8300M, LX-8100, LX-7230N), while the EFS-1000 provides ECG data management and the CVW-6000 enables centralized data viewing via web browsers.

Differentiator

Problem solved

Functional benefit

Brands

• DYNASCOPE: Patient monitoring systems product line
• CardiMax
• VaSera

Products and services

• Electrocardiograph (ECG) Machines
• Patient Monitors
• Telemetry Transmitters
• Vascular Screening Systems

Quantifiable outcome

• 336 hours (14 days) of continuous waveform storage on DS-1800 central monitor
• +3 more outcomes

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Boston Scientific JapancoreChannel Partner/ Reseller/ Distributor · 20 January 2011Fukuda Denshi entered into a Basic Agreement with Boston Scientific Japan for domestic distribution of pacemakers and related products in Japan. This partnership established Boston Scientific Japan as a distributor for Fukuda's cardiac rhythm management products.
• Exclusive Distribution Partner for Electrode CatheterscoreChannel Partner/ Reseller/ Distributor · 11 January 2011Fukuda Denshi established a business alliance for exclusive distribution of electrode catheters for cardiac electrophysiological testing. This partnership enabled expanded distribution of diagnostic catheters used in electrophysiology procedures.
• St. Jude Medical Inc.minorChannel Partner/ Reseller/ Distributor · 17 December 2010Fukuda Denshi ended its domestic distributorship agreement with St. Jude Medical Inc. in December 2010. Prior to this termination, St. Jude Medical had been distributing certain Fukuda products in Japan.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Hillrom / Baxter Patient Monitoring: Includes the legacy Mortara Instrument ECG business now under Baxter. Direct competitor in resting ECG, stress ECG, and Holter analysis with established US hospital channel presence.
• Dräger: German medical and safety technology company with a strong patient monitoring portfolio including anesthesia, ICU, and neonatal monitoring. Overlaps with Fukuda in critical care bedside and central monitoring.
• GE HealthCare: Global medical device giant with a broad portfolio spanning patient monitoring, ECG, imaging, and ultrasound. Directly competes with Fukuda in central monitoring and ECG markets but operates at much greater scale and offers a wider product portfolio.
• Philips Healthcare: Major provider of patient monitoring, ECG, and cardiology solutions globally. Overlaps directly with Fukuda across hospital monitoring and cardiology diagnostics, with substantially larger R&D resources and an established hospital IT ecosystem.
• Welch Allyn (Baxter): Now part of Baxter, Welch Allyn has historical strength in vital signs monitoring and ECG. Overlaps with Fukuda in cardiology diagnostics and patient monitoring within US clinical settings.
• Medtronic: Largest medical device company globally, with significant presence in cardiac rhythm management, ECG, and Holter monitoring. Competes with Fukuda in Holter analysis and cardiology diagnostics but operates at far greater scale with broader therapeutic offerings.

Direct peers

• Nihon Kohden: Japanese-headquartered medical electronics company specializing in patient monitoring, ECG, and EEG equipment. Nihon Kohden is Fukuda's closest comparable in terms of Japanese heritage, ECG expertise, and global patient monitoring portfolio.
• Spacelabs Healthcare: US-based patient monitoring and ECG company owned by OSI Systems. Directly competes with Fukuda in bedside patient monitoring and central station products, particularly in the US hospital market.
• Mindray: Chinese-headquartered medical device manufacturer with strong presence in patient monitoring, ECG, and in-vitro diagnostics. Competes with Fukuda in bedside and central monitoring markets, particularly across Asia-Pacific and emerging markets.
• Schiller AG: Swiss-based medical device company specializing in cardiology, ECG, and patient monitoring. A closely comparable mid-sized competitor with similar focus on resting ECG, stress testing, and Holter systems.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fukuda-denshi-usa-inc

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FUKUDA DENSHI USA Inc